Other languages NeuroMetrix, Inc.

Equities

NURO

US6412558800

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
4.44 ^USD	+1.60%		+2.54%	+23.33%

04-19	Sector Update: Health Care Stocks Advance Late Afternoon	MT
04-19	Sector Update: Health Care Stocks Rise Friday Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neurometrix, Inc. Appoints Joshua S. Horowitz as a Class III director on the Board	04-19
NeuroMetrix, Inc. Announces Publication of Study Demonstrating That DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	03-14
Ephraim Fields Discloses his Views on NeuroMetrix	02-27
RS Fund Discloses its Views on NeuroMetrix	02-26
NeuroMetrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-22
NeuroMetrix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	02-13
Neurometrix, Inc. Reports Encouraging Results from Pilot Clinical Trial of Quell®? in Post-Acute Covid-19 Syndrome (Long Covid)	12-12
NeuroMetrix, Inc. Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy	12-05
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	11-20
Sector Update: Health Care Stocks Advance in Afternoon Trading	11-20
NeuroMetrix Announces 1-for-8 Reverse Stock Split; Shares Fall	11-20
NeuroMetrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
NeuroMetrix, Inc. and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia	02/10/23
NeuroMetrix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	27/07/23
NeuroMetrix, Inc. Announces Sales Force Expansion for Quell Fibromyalgia	11/07/23
NeuroMetrix, Inc. Announces Presentation of New Clinical Data At the Diabetes UK Meeting	07/06/23
Sector Update: Health Care Stocks Advancing Late Wednesday	31/05/23
Sector Update: Health Care Stocks Higher in Afternoon Trading	31/05/23
NeuroMetrix Reports 'Encouraging' Results of Chemotherapy-Induced Peripheral Neuropathy Clinical Trial	31/05/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NeuroMetrix, Inc.

Equities

NURO

US6412558800

Other languages

Filters